These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33236939)

  • 1. An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK.
    Shore J; Russell J; Frankenstein L; Candolfi P; Green M
    J Med Econ; 2020 Dec; 23(12):1425-1434. PubMed ID: 33236939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
    Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation.
    Cameron HL; Bernard LM; Garmo VS; Hernandez JB; Asgar AW
    J Med Econ; 2014 Aug; 17(8):599-615. PubMed ID: 24826880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation.
    Cohen DJ; Wang K; Magnuson E; Smith R; Petrie MC; Buch MH; Abraham W; Lindenfeld J; Mack MJ; Stone GW; Cleland JGF
    Heart; 2022 May; 108(9):717-724. PubMed ID: 35078867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cost-effectiveness of transcatheter mitral valve repair in  HF patients with secondary mitral regurgitation.
    Yao Y; Zhou Z; Geng T; Cai A; Li T; Yang J; Chen J; Li L
    ESC Heart Fail; 2024 Aug; 11(4):2023-2032. PubMed ID: 38515335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison.
    Ludwig S; Conradi L; Cohen DJ; Coisne A; Scotti A; Abraham WT; Ben Ali W; Zhou Z; Li Y; Kar S; Duncan A; Lim DS; Adamo M; Redfors B; Muller DWM; Webb JG; Petronio AS; Ruge H; Nickenig G; Sondergaard L; Adam M; Regazzoli D; Garatti A; Schmidt T; Andreas M; Dahle G; Walther T; Kempfert J; Tang GHL; Redwood S; Taramasso M; Praz F; Fam N; Dumonteil N; Obadia JF; von Bardeleben RS; Rudolph TK; Reardon MJ; Metra M; Denti P; Mack MJ; Hausleiter J; Asch FM; Latib A; Lindenfeld J; Modine T; Stone GW; Granada JF;
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e013045. PubMed ID: 37194288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    Mack MJ; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Grayburn PA; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Rogers JH; Marx SO; Cohen DJ; Weissman NJ; Stone GW;
    J Am Coll Cardiol; 2021 Mar; 77(8):1029-1040. PubMed ID: 33632476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
    Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
    Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
    JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Hahn RT; Asch FM; Weissman NJ; Medvedofsky D; Puri R; Kapadia S; Sannino A; Grayburn P; Kar S; Lim S; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Dec; 76(22):2595-2606. PubMed ID: 33243380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.
    Malik UI; Ambrosy AP; Ku IA; Mishell JM; Kar S; Lim DS; Whisenant BK; Cohen DJ; Arnold SV; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2331-2341. PubMed ID: 33092707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of percutaneous mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation in Japan.
    Sakamaki H; Nakao K; Matsumoto T; Inoue S
    J Med Econ; 2019 Dec; 22(12):1312-1320. PubMed ID: 31516049
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure.
    Kosmidou I; Lindenfeld J; Abraham WT; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Gaba P; Rogers JH; Shahim B; Redfors B; Zhang Z; Mack MJ; Stone GW
    JACC Heart Fail; 2021 Sep; 9(9):674-683. PubMed ID: 34391744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.
    Saxon JT; Cohen DJ; Chhatriwalla AK; Kotinkaduwa LN; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Arnold SV; Stone GW
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2795-2803. PubMed ID: 33303119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation: a systematic review.
    Rezapour A; Azari S; Arabloo J; Pourasghari H; Behzadifar M; Alipour V; Omidi N; Sadeghian S; Aghajani H; Bragazzi NL
    Heart Fail Rev; 2021 May; 26(3):587-601. PubMed ID: 33230582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation.
    Estler B; Rudolph V; Seleznova Y; Shukri A; Stock S; Müller D
    Eur J Health Econ; 2023 Apr; 24(3):349-358. PubMed ID: 35622185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network.
    Ferket BS; Ailawadi G; Gelijns AC; Acker M; Hohmann SF; Chang HL; Bouchard, D; Meltzer DO; Michler RE; Moquete EG; Voisine P; Mullen JC; Lala A; Mack MJ; Gillinov AM; Thourani VH; Miller MA; Gammie JS; Parides MK; Bagiella E; Smith RL; Smith PK; Hung JW; Gupta LN; Rose EA; O'Gara PT; Moskowitz AJ; Cardiothoracic Surgical Trials Network (CTSN) Investigators
    Circ Cardiovasc Qual Outcomes; 2018 Nov; 11(11):e004466. PubMed ID: 30785252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.